Two Sigma Advisers’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-109,100
Closed -$542K 2591
2023
Q4
$542K Sell
109,100
-142,300
-57% -$707K ﹤0.01% 1892
2023
Q3
$1.27M Sell
251,400
-160,000
-39% -$876K ﹤0.01% 1424
2023
Q2
$2.07M Sell
411,400
-173,000
-30% -$1.13M 0.01% 1182
2023
Q1
$3.59M Buy
584,400
+25,200
+5% +$206K 0.01% 961
2022
Q4
$7.38M Buy
559,200
+146,669
+36% +$1.03M 0.02% 611
2022
Q3
$1.23M Sell
412,531
-130,769
-24% -$555K ﹤0.01% 1423
2022
Q2
$1.98M Buy
543,300
+11,000
+2% +$52.3K 0.01% 1221
2022
Q1
$3.29M Buy
532,300
+5,400
+1% +$33.5K 0.01% 1000
2021
Q4
$4.27M Buy
526,900
+48,500
+10% +$522K 0.01% 837
2021
Q3
$7.13M Buy
+478,400
New +$5.96M 0.02% 630
2020
Q3
Sell
-32,800
Closed -$66K 2585
2020
Q2
$66K Buy
+32,800
New +$36.5K ﹤0.01% 2407
2019
Q1
Sell
-3,155
Closed -$20K 2422
2018
Q4
$20K Sell
3,155
-20
-0.6% -$265 ﹤0.01% 2310
2018
Q3
$52K Buy
3,175
+1,535
+94% +$27.6K ﹤0.01% 2173
2018
Q2
$34K Buy
+1,640
New +$34.2K ﹤0.01% 2316

Other funds holding PDSB